Surgical treatment of chronic pulmonary aspergillosis using preventive latissimus dorsi muscle flaps

Table 2 Surgical procedures and postoperative clinical courses

No.	Age	Surgical	Blood Loss	Complication		Hospital
No.	/sex	Procedure	(mL)	(in hospital)	(after discharge)	stay^a (days)
1	60	Lobectomy	381	Respiratory failure (requiring home oxygen therapy at discharge)	Pneumonia	16
1	/m	with MF + TP	381		Pneumonia	16
2	61	Lobectomy	940	-		20
2	/m	with MF
3	74	Lobectomy	457	-		16
3	/m	with MF
4	69	Lobectomy	2225	-		10
4	/m	with MF
5	55	Lobectomy	1491	-	Late onset air leak	14
5	/m	with MF			+ Recurrence
6	68	Lobectomy	608	-		31
6	/m	With MF
7	56	Lobectomy	1500	-	Late onset air leak	18
7	/f				+ Recurrence
8	58	Lobectomy	651	-		10
8	/m
9	71	Lobectomy	715	-		16
9	/m
10	75	Lobectomy	132	-		8
10	/m
11	61	Lobectomy	240	-		10
11	/m
12	67	Lobectomy	855	Respiratory failure (requiring home oxygen		58
12	/f			therapy at discharge)
13	64	Lobectomy	180	-		7
13	/m
14	75	Lobectomy	1021	Prolonged air leak		72
14	/m			Empyema
15	78	Lobectomy	210	-	Pneumonia	30
15	/m
16	50	Partial resection	trace	Prolonged air leak		31
16	/m			Empyema

m male, f female, MF muscle flap, TP thoracoplasty, ^aHospitalization stay length following surgery

ISSN: 1749-8090